Colin W Howden

9PUBLICATIONS
9CO-AUTHORS
Behavioural epidemiologyClinical pharmacology and therapeuticsPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 02, 2025
Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.

Nimish Vakil, Colin W Howden, Shailja C Shah

|Oct 28, 2024
The Role of P-CABs in GERD.

Colin W Howden

|Apr 21, 2023
Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection.

Colin W Howden, Shailja Shah, Salil N Pendse

|Apr 17, 2023
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection.

Carmelo Scarpignato, Colin W Howden, Eckhard Leifke

|Feb 16, 2021
Review article: potassium-competitive acid blockers for the treatment of acid-related disorders.

Yousef Abdel-Aziz, David C Metz, Colin W Howden

Pageof 2

Frequent Collaborators

2 joint publications

Shailja Shah

2 joint publications

June S Almenoff

2 joint publications

Kely L Sheldon

1 joint publications

Carmelo Scarpignato